Convergence Investment Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.19M	Buy	+54,906	New	+$1.19M	0.3%	124
2023 Q1	–	Sell	-7,935	Closed	-$148K	–	195
2022 Q4	$148K	Buy	+7,935	New	+$148K	0.09%	184